- Home
- TLRY vs NMAI Comparison
TLRY vs NMAI Comparison
Compare TLRY & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | NMAI |
|---|---|---|
| Founded | N/A | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.3M | 458.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | NMAI |
|---|---|---|
| Price | $4.09 | $14.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $72.33 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 80.9K |
| Earning Date | 04-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | ★ 55.69 | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | ★ N/A | $22.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $11.99 |
| 52 Week High | $15.70 | $15.06 |
Technical Indicators
Market Signals| Indicator | TLRY | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 44.02 |
| Support Level | $3.87 | $13.59 |
| Resistance Level | $4.91 | $14.30 |
| Average True Range (ATR) | 0.15 | 0.21 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 33.58 | 39.33 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.